11/01/2024
3:35 PM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:30 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/19/2024
6:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:19 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:41 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:48 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
3:24 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
3:28 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:14 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:18 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:53 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:15 PM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024
3:09 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:05 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:08 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
7:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
4:01 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
5:39 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:23 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:01 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:28 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:33 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:06 AM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
02/05/2024
8:21 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
1:40 PM | BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/10/2024
3:08 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
4:01 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:00 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
11/16/2023
3:31 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
3:14 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
3:24 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
